Answers are grounded in this paper and cite their sources.
AbstractLimonene the current study focuses on the development, optimization, and testing of a limonene-loadedtopical emulgel with antioxidant properties. Limonene, a natural monoterpene produced from citrusoils, has strong antioxidant, anti-inflammatory, and skin-penetration boosting capabilities, but has lowwater solubility and high volatility, restricting its topical application. To address these issues, emulgelswere created with Carbopol 940 as the gelling agent, lecithin as the emulsifier, and olive oil as the lipidphase, which improved stability and bioavailability. Five formulations (F1-F5) were created bychanging the quantities of carbopol and lecithin to enhance physicochemical and functional properties.The improved batch (F3) achieved optimal pH (6.3 ± 0.1), viscosity (16,870 ± 1.2 cps), spreadability(6.4 cm·g/s), and drug content (99.1%). In vitro diffusion tests indicated sustained drug release (97.5%)over 8 hours using Higuchi kinetics, demonstrating matrix-controlled release. The antioxidant activity,as assessed by the DPPH experiment, demonstrated high radical scavenging potential (84.6% inhibition)when compared to pure limonene. Stability testing indicated that the improved formulation hadoutstanding physical and chemical stability under accelerated conditions. Overall, the study found thatthe limonene-loaded emulgel is an effective, stable, and patient-friendly topical solution that improvesdrug retention, antioxidant protection, and therapeutic potential in dermatological applications.
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: